ArticlePDF Available

Phototherapy with combination of super-pulsed laser and light-emitting diodes is beneficial in improvement of muscular performance (strength and muscular endurance), dyspnea and fatigue sensation in patients with chronic obstructive pulmonary disease

Authors:
  • University Center of Anápolis - UniEvangelica
  • Universidade Nove de Julho / Vrije Universiteit Amsterdam

Abstract and Figures

Phototherapy is an electrophysical intervention being considered for the retardation of peripheral muscular fatigue usually observed in chronic obstructive pulmonary disease (COPD). The objective of this study was to evaluate the acute effects of combination of super-pulsed laser and light-emitting diodes phototherapy on isokinetic performance in patients with COPD. Thirteen patients performed muscular endurance tests in an isokinetic dynamometer. The maximum voluntary isometric contraction (MVIC), peak torque (PT), and total work (TW) of the non-dominant lower limb were measured in two visits. The application of phototherapy or placebo (PL) was conducted randomly in six locations of femoral quadriceps muscle by using a cluster of 12 diodes (4 of 905 nm super-pulsed lasers, 0.3125 mW each; 4 of 875 nm LEDs, 17.5 mW each; and 4 of 640 nm LEDs, 15 mW each, manufactured by Multi Radiance Medical™). We found statistically significant increases for PT (174.7 ± 35.7 N · m vs. 155.8 ± 23.3 N · m, p = 0.003) and TW after application of phototherapy when compared to placebo (778.0 ± 221.1 J vs. 696.3 ± 146.8 J, p = 0.005). Significant differences were also found for MVIC (104.8 ± 26.0 N · m vs. 87.2 ± 24.0 N · m, p = 0.000), sensation of dyspnea (1 [0-4] vs. 3 [0-6], p = 0.003), and fatigue in the lower limbs (2 [0-5] vs. 5 [0.5-9], p = 0.002) in favor of phototherapy. We conclude that the combination of super-pulsed lasers and LEDs administered to the femoral quadriceps muscle of patients with COPD increased the PT by 20.2 % and the TW by 12 %. Phototherapy with a combination of super-pulsed lasers and LEDs prior to exercise also led to decreased sensation of dyspnea and fatigue in the lower limbs in patients with COPD.
Content may be subject to copyright.
ORIGINAL ARTICLE
Phototherapy with combination of super-pulsed laser
and light-emitting diodes is beneficial in improvement
of muscular performance (strength and muscular endurance),
dyspnea, and fatigue sensation in patients with chronic
obstructive pulmonary disease
Eduardo Foschini Miranda &Luís Vicente Franco de Oliveira &
Fernanda Colella Antonialli &Adriane Aver Vanin &
Paulo de Tarso Camillo de Carvalho &Ernesto Cesar Pinto Leal-Junior
Received: 5 August 2014 /Accepted: 5 November 2014
#Springer-Verlag London 2014
Abstract Phototherapy is an electrophysical intervention be-
ing considered for the retardation of peripheral muscular fatigue
usually observed in chronic obstructive pulmonary disease
(COPD). The objective of this study was to evaluate the acute
effects of combination of super-pulsed laser and light-emitting
diodes phototherapy on isokinetic performance in patients with
COPD. Thirteen patients performed muscular endurance tests
in an isokinetic dynamometer. The maximum voluntary iso-
metric contraction (MVIC), peak torque (PT), and total work
(TW) of the non-dominant lower limb were measured in two
visits. The application of phototherapy or placebo (PL) was
conducted randomly in six locations of femoral quadriceps
muscle by using a cluster of 12 diodes (4 of 905 nm super-
pulsed lasers, 0.3125 mW each; 4 of 875 nm LEDs, 17.5 mW
each; and 4 of 640 nm LEDs, 15 mW each, manufactured by
Multi Radiance Medical). We found statistically significant
increases for PT (174.7±35.7 N·m vs. 155.8±23.3 N·m, p=
0.003) and TW after application of phototherapy when com-
pared to placebo (778.0±221.1 J vs. 696.3±146.8 J, p=0.005).
Significant differences were also found for MVIC (104.8±
26.0 N·m vs. 87.2±24.0 N·m, p=0.000), sensation of dyspnea
(1 [04] vs. 3 [06], p=0.003), and fatigue in the lower limbs (2
[05] vs. 5 [0.59], p=0.002) in favor of phototherapy. We
conclude that the combination of super-pulsed lasers and LEDs
administered to the femoral quadriceps muscle of patients with
COPDincreasedthePTby20.2%andtheTWby12%.
Phototherapy with a combination of super-pulsed lasers and
LEDs prior to exercise also led to decreased sensation of
dyspnea and fatigue in the lower limbs in patients with COPD.
Keywords Chronic obstructive pulmonary disease .
Phototherapy .Fatigue
Introduction
Chronic obstructive pulmonary disease (COPD) is a pulmo-
nary pathological disorder that evolves with systemic mani-
festations including significant adverse effects on peripheral
muscle function and changes to the structure and metabolism
of the peripheral muscles, leading to decreased muscle
strength and endurance [1]. Factors that may be responsible
for premature muscle fatigue in this population include the
reduction of muscle strength, decrease in aerobic capacity,
dependence on glycolytic metabolism, and the fast buildup
of lactate during exercise [2]. Therefore, eletrophysical inter-
ventions such as phototherapy with lasers, light-emitting di-
odes (LEDs), or the combination of both are being studied to
minimize or delay muscle fatigue.
Several studies have used phototherapy as a non-invasive
therapeutic modality to increase muscle vasodilation [3], im-
prove collateral circulation, increase the level of oxygen in the
E. F. Miranda :P. C. de Carvalho :E. P. Leal-Junior
Post-Graduate Program in Biophotonics Applied to Health Sciences,
Nove de Julho University, Rua Vergueiro, 235, 01504-001
São Paulo, SP, Brazil
L. V. F. de Oliveira :F. C. Antonialli :A. A. Vanin :
P. C. de Carvalho :E. P. Leal-Junior (*)
Post-Graduate Program in Rehabilitation Sciences,
Nove de Julho University, São Paulo, Brazil
e-mail: ernesto.leal.junior@gmail.com
Lasers Med Sci
DOI 10.1007/s10103-014-1690-5
tissue, and increase adenosine triphosphate (ATP) in periph-
eral muscle mitochondria [47]. Many studies have used
phototherapy in the treatment of muscular disorders such as
fatigue in postmenopausal women during endurance training
[8]andforneckpain[9,10]. In addition, the ability of
phototherapy to reduce inflammatory processes and decrease
oxidative stress is also beneficial in muscular and sports-
related injuries [11,12]. The physiological changes caused
by phototherapy therefore have an important role in the pre-
vention and recovery of muscular fatigue.
In a previous study, Miranda et al. [13] were the first to study
the effect of phototherapy with LEDs in patients with COPD.
The authors found a decrease in the median frequency of
electromyographic outcome for evaluation of muscle fatigue
after isometric endurance testing and an increase in a muscular
endurance time test in ten patients with COPD after application
of LED phototherapy in the femoral quadriceps muscle.
As previous studies have shown beneficial effects by using
different wavelengths for enhancing muscle performance in
animal experiments [7,14,15], we hypothesized that a combi-
nation of super-pulsed lasers and LEDs could be a promising
alternative in preventing muscular fatigue induced by exercise in
patients with COPD. Furthermore, this is an innovative, non-
invasive, and non-pharmacological therapy. The purpose of this
study was to evaluate the acute effects of combined super-pulsed
laser and LED phototherapy on the isokinetic performance
(strength and muscular endurance) of patients with COPD.
Methods
Thirteen patients were consecutively recruited from the out-
patient chronic pulmonary diseases clinic at the Nove de Julho
University. All patients had a diagnosis of COPD according to
the global initiative for chronic obstructive lung disease
(GOLD) criteria [16]. The patients were at a stable phase of
the disease indicated by no change in the medical therapy
(including oral steroids) or exacerbation of symptoms in the
preceding 4 weeks. Patients with other known severe chronic
diseases, including cardiac, neuromuscular, or orthopedic dis-
orders, were excluded. The study was approved by the insti-
tutional ethics committee (process 632.222), and written in-
formed consent was obtained from all patients.
Randomization and blinding procedures
Randomization was performed by simple drawing of lots,
which was used to determine whether the active combination
of super-pulsed laser and LEDs phototherapy or placebo
would be given at the first session. Participants were crossed
over to receive whichever treatment was not given at the first
session. Randomization labels were created by using a ran-
domization table at a central office where a series of sealed,
opaque, and numbered envelopes were used to ensure
confidentiality. A participating researcher who had the func-
tion of programming the phototherapy device based on the
randomization results conducted randomization. This re-
searcher was instructed not to inform the participants or
other researchers regarding the phototherapy dose. Thus,
the researcher in charge of the administration of the pho-
totherapy was blinded to the dose applied to the volunteers.
Blinding was further maintained by the use of opaque
goggles by the participants.
Study design and protocol
A crossover, double-blinded, placebo-controlled, and ran-
domized clinical trial was carried out. The study was
conducted in the Laboratory of Phototherapy in Sport and
Exercise at the Nove de Julho University, São Paulo,
Brazil. Patients were administered either phototherapy or
placebo treatments on two visits, 1 week apart. Immediate-
ly after the application, the maximum voluntary isometric
contraction (MVIC) was determined and the endurance
testtotal work (TW). A summary of the protocol is
presented in Fig. 1.
Procedures
Spirometry
Spirometry (Koko Spirometer, AL, USA) was performed as
per the American Thoracic Society/European Respiratory So-
ciety criteria [17]; FVC, FEV
1
,andFEV
1
/FVC are expressed as
absolute values and percent of predicted [18].
Fig. 1 CONSORT flow chart
Lasers Med Sci
Isokinetic protocol
An isokinetic dynamometer (System 4, Biodex®, USA)
was used for the evaluation of muscle function and the
execution of the exercise protocol. This is currently con-
sidered the method with the greatest reliability for the
measure of musculoskeletal performance. For the MVIC
test, the volunteers sat at an angle of 100° between the
trunk and hips with the non-dominant leg positioned with
the knee at 60° of flexion (0° corresponds to complete
knee extension) and were strapped to the dynamometer
seat. The dominant leg was positioned at 100° of hip
flexion and was strapped to the seat. The volunteers were
fastened to the seat of the dynamometer by using two
additional straps crossing the trunk. The volunteers were
instructed to cross their arms over their trunk, and the axis of
the dynamometer was positioned parallel to the center of the
knee.
The MVIC test consisted of three 5-s isometric con-
tractions of the knee extensors of the non-dominant leg.
The highest torque value of the three contractions (peak
torque [PT]) was used for the statistical analysis. This
parameter was chosen because it reflects the maximum
generation of force by the muscle. Instructions on how
to execute the test were given prior to testing, and the volun-
teers received verbal encouragement during the execution of
the test.
A resting period of 60 s was allowed, followed the
MVIC test after which volunteers performed a familiar-
ization isokinetic protocol. The familiarization consisted
of five submaximal voluntary repetitions of knee
flexion-extension in an eccentric contraction protocol,
followed by a resting period of 60 s. The eccentric
contraction protocol consisted of 20 eccentric, isokinetic
contractions of the knee extensor musculature in the
non-dominant leg (two sets of ten repetitions, 30 s rest
intervals between sets) at a velocity of 60° seg
1
in
both the eccentric and concentric movements with a
60° range of motion (between 90° and 30° of knee
flexion). At each contraction, the dynamometer automat-
ically (passively) positioned the knee at 30°; the dyna-
mometer then flexed the knee until reaching 90°. The
volunteers were instructed to resist against knee flexion
movement imposed by the dynamometer with maximum
force. Despite the diversity of protocols proposed for
the execution of eccentric exercises on isokinetic dyna-
mometers, we used a modified protocol based on a
previous study carried out by our research group [19]
in which this method proved effective and reproducible
for the exercise-induced muscle damage. The researcher
in charge of the eccentric contractions protocol was
blinded to randomization and allocation of volunteers
to experimental groups.
Before and after the endurance test, the perceived effort
(dyspnea and leg fatigue) was assessed by using the modified
Borg scale [20].
Phototherapy
Patients received a single application of combined super-
pulsed laser and LED phototherapy or placebo 1 week
apart. The phototherapy combining super-pulsed laser
and LEDs or placebo was administered immediately be-
fore the testing of lower limb isokinetic dynamometry. A
12-diode cluster of super-pulsed laser and LEDs was
used. Each cluster consisted of four diodes of super-
pulsed laser (905 nm, 0.3125 mW average power and
12.5 W peak power for each diode), four diodes of
infrared LEDs (875 nm, 17.5 mW average power for
each diode), and four diodes of red LEDs (640 nm,
15 mW average power for each diode); they were
manufactured by Multi Radiance Medical(Solon,
OH, USA). In view of the extensive area of radiation
employed in this project, the use of clusters becomes
fundamental to the application of the therapy. The appli-
cation of phototherapy was held with the cluster in direct
contact with the skin, at six sites of the quadriceps
femoris (two centrally, rectus femoris and vastus
intermedius; two laterally, vastus lateralis; and two me-
dially, vastus medialis). For placebo, the same proce-
dures were performed, but without irradiation. During
the application of combined super-pulsed laser and LEDs
phototherapy or placebo, the patient wore protective
goggles to prevent them from seeing whether or not there
was light being radiated.
Since the cluster has 12 diodes that were used to irradiate
six different locations of the extensor muscles of the knee (as
illustrated in Fig. 2), a total of 72 points in the musculature
were irradiated. Phototherapy parameters were chosen based
on a previous study performed by our research group [15].
Table 1provides a full description of the phototherapy
parameters.
Statistical analysis
The intention-to-treat analysis was followed. The Kol-
mogorovSmirnovtestwasusedtoverifythenormal
distribution of data. Parametric data were expressed as
mean and standard deviation. Non-parametric data were
expressed as median and interquartile intervals. Differ-
ences in the variables of muscle function between com-
bined phototherapy and placebo treatments were com-
pared by using paired, two-sided Studentsttests, and
the differences of Borg scale were compared by using
the Wilcoxon test. The level of statistical significance was set
at p<0.05.
Lasers Med Sci
Results
Our volunteer population was formed mostly by patients with
moderate COPD according to the GOLD [16]criteria(GOLD
2, n=7), with the remaining patients classified as having mild
(GOLD 1, n=1), severe (GOLD 3, n=4), and very severe
(GOLD 4, n=1) COPD. Table 2summarizes the characteris-
tics of the patients.
A statistically significant difference was found for the
increase of PT after the application of combined super-
pulsed laser and LED phototherapy when compared with the
placebo (174.7 ±35.7 N· m vs. 155.8 ±23.3 N·m, respectively;
p=0.003). A similar finding was found for MVIC, with values
of 104.8±26.0 N·m vs. 87.2±24.0 N· m for the phototherapy
treatment and placebo, respectively (p= 0.000). Fig. 3a, b sum-
marizes the outcomes.
A greater value in the TW was observed during endurance
testing with the combination of super-pulsed laser and LED
phototherapy when compared to the placebo (778.0±221.1 J
vs. 696.3±146.8 J, respectively; p=0.005Fig. 4).
The dyspnea score after the combination of super-pulsed laser
and LED phototherapy was lower in comparison with the place-
bo (1 [04] vs. 3 [06], p=0.003), and a similar result was seen in
the fatigue score for the lower limbs (2 [05] vs. 5 [0.59],
respectively; p=0.002). The findings are summarized in Fig. 5.
Discussion
To the best of our knowledge, this is the first study to analyze
the acute effects of the combination of super-pulsed laser and
LED phototherapy on isokinetic performance in patients with
Fig. 2 Illustration of irradiation areas of phototherapy
Tabl e 1 Phototherapy parameters
Number of lasers 4 super-pulsed infrared
Wavelength (nm) 905
Frequency (Hz) 250
Peak power (W)each 12.5
Average optical output (mW)each 0.03125
Power density (mW/cm
2
)each 0.07
Dose (J)each 0.07125
Spot size of laser (cm
2
)each 0.44
Number of red LEDs 4 red
Wavelength of red LEDs (nm) 640
Frequency (Hz) 2
Average optical output (mW)each 15
Power density (mW/cm
2
)each 16.66
Dose (J)each 3.42
Spot size of red LED (cm
2
)each 0.9
Number of infrared LEDs 4 infrared
Wavelength of infrared LEDs (nm) 875
Frequency (Hz) 16
Average optical output (mW)each 17.5
Power density (mW/cm
2
)each 19.44
Dose (J)each 3.99
Spot size of LED (cm
2
)each 0.9
Magnetic field (mT) 35
Irradiation time per site (sec) 228
Total dose per si te (J ) 30
Total dose applied in muscular group (J) 180
Aperture of device (cm
2
)20
Tabl e 2 Vol u n tee r s characteristics
Va ri ab le s M ea n ± SD
Age, years 61±6
BMI, kg/m
2
24.3±4.1
FVC, L (% predicted) 2.5±0.7 (74±15)
FEV
1
, L (% predicted) 1.2±0.4 (53±16)
FEV
1
/FVC ratio, % 60.3±12.2
BMI body mass index, FVC forced vital capacity, FEV
1
forced expiratory
volume in 1 s in liters and in percentage of predicted, L (% predicted) in
liters and in percentage of predicted
Lasers Med Sci
COPD. Briefly, we found that combining lasers and LEDs
significantly increased the PT, TW, and MVIC, and decreased
dyspnea and lower limb fatigue in patients with COPD.
The beneficial use of phototherapy with a combination of
lasers and LEDs has been described recently in the literature.
Antonialli et al. [15] used phototherapy with a combination of
lasers and LEDs to test muscle performance and recovery after
exercise. The authors found an increased MVIC, decreased
biochemical levels of CK, and a decrease in the pain assess-
ment scale, when compared to placebo after an eccentric
protocol in an isokinetic dynamometer. In our study,
we did not evaluate biochemical markers and muscle
pain. However, we found a decreased sensation of dyspnea
and fatigue in the lower limbs assessed by using the Borg
scale, suggesting that the phototherapy with the combination
of lasers and LEDs was able to improve these parameters after
isokinetic exercise.
The combination of lasers and LEDs has also been used to
investigate the effects of phototherapy on non-specific knee
pain. The outcomes evaluated in this study were pain (evalu-
ated by using the visual analog scale) and quality of life
(measured by using the quality of life questionnaire SF-
36®). Phototherapy significantly decreased pain and im-
proved quality of life when compared with the placebo in
patients with knee pain [21]. In our study, the outcomes
evaluated were the variables obtained during an isokinetic
protocol and assessment of dyspnea and fatigue in the lower
limbs by using the Borg scale. We believe that a low score on
the Borg scale after application of phototherapy can be a good
indicator of improvement in the physical capacity of individ-
uals with COPD.
Miranda et al. [13] were the first to evaluate the
acute effect of phototherapy on quadriceps femoris mus-
cle function during isometric exercise in patients with
COPD. Phototherapy treatment was found to increase endur-
ance by 18 % and had a smaller decline on the median
Fig. 3 a,bComparison values of isokinetic protocol (PT and MVIC)
Fig. 4 Total work (TW) with combination of super-pulsed laser and
light-emitting diodes phototherapy compared to placebo
Fig. 5 Comparison of the Borg scale after phototherapy or placebo
Lasers Med Sci
frequency ofelectromyographic outcome for the evaluation of
muscle fatigue when contrasted with placebo. Corroborating
our previous findings, we observed a 20.2 % increase in
MVIC after application of phototherapy when compared with
placebo.
Similar to our study, Paolillo et al. [22]reportedan8.5%
increase in TWassessed by using an isokinetic dynamometer
in 20 postmenopausal women after application of photother-
apy when compared with the control group. We found a 12 %
increase in TW in our study that may be attributable to
differences in the study populations and the isokinetic proto-
col used by Paolillo et al. [22].
Although the present study is the first to use the combina-
tion of lasers and LEDs in patients with COPD, our findings
indicated that the magnitude of effect observed was higher
than that observed in other studies [13,15,21,22]. We believe
the best results were obtained owing to the combination of
different wavelengths (905, 875, and 640 nm) and different
sources of light (super-pulsed-laser and LEDs) used in our
study.
In animal studies, Albuquerque-Pontes et al. [7]radiated
the tibialis anterior muscle of rats with different wavelengths
(660, 830, and 905 nm). The authors found a significant
increase of cytochrome c oxidase. This finding contributes
to the understanding of how phototherapy can increase mus-
cular performance and protect against the development of
skeletal muscle fatigue and damage tissue [7].
The use of different wavelengths (660, 830, and 905 nm)
was investigated by Santos et al. [14] to evaluate the effects of
phototherapy immediately before tetanic contractions in the
development of skeletal muscle fatigue and possible tissue
damage in rats. The study showed that optimal doses of
phototherapy could slow the development of muscle fatigue
and protect against muscle tissue damage. The optimal doses
were, in part, dependent on specific wavelengths, and there-
fore must be differentiated to obtain the optimal effects for
tissue preservation and muscular fatigue.
The simultaneous use of different wavelengths may in-
crease the effects of phototherapy on skeletal muscle perfor-
mance and may represent a therapeutic advantage in clinical
situations, which was observed in the present study and in
previous studies [15,21]. One of the possible explanations for
the increase in isokinetic variables after applying the combi-
nation of lasers and LEDs is increased microcirculation
around the irradiated area. According to some authors
[2326], increased local blood flow is able to reduce the
buildup of blood lactate and increase the supply of oxygen
to muscle tissues, thereby reducing muscle fatigue.
Based on these findings and previous studies, photo-
therapy with the combination of laser super-pulsed and
LEDs can be considered as a new and non-invasive
treatment to reduce fatigue and increase muscle strength in
patients with COPD.
Conclusion
In this study, we demonstrate that a combination of super-
pulsed laser and LED phototherapy on the femoral quadriceps
muscle in patients with COPD was able to increase PT by
20.2 % and TW by 12 %. Furthermore, combined photother-
apy prior to exercise still led to a decreased sensation of
dyspnea and lower limb fatigue in patients with COPD.
Funding Professor Ernesto CesarPinto Leal-Junior would like tothank
the São Paulo Research FoundationFAPESP (grant number
2010/52404-0) and Brazilian Council of Science and Technology Devel-
opmentCNPq (grant number 472062/2013-1).
Conflict of interest Professor Ernesto Cesar Pinto Leal-Junior receives
a research support from Multi Radiance Medical (Solon, OH, USA), a
laser device manufacturer. The remaining authors declare that they have
no conflict of interest.
References
1. Breunung L, Roberts M (2011) Peripheral muscle dysfunction and
chronic obstructive pulmonary disease. Br J Hosp Med (Lond) 72(1):
1718
2. Miranda EF, Malaguti C, Dal Corso S (2011) Peripheral muscle
dysfunction in COPD: lower limbs versus upper limbs. J Bras
Pneumol 37(3):380388
3. Leal-Junior EC, Lopes-Martins RA, Baroni BM, De Marchi T, Rossi
RP, Grosselli D, Generosi RA, de Godoi V, Basso M, Mancalossi JL,
Bjordal JM (2009) Comparison between single-diode low-level laser
therapy (LLLT) and LEDT multi-diode (cluster) therapy (LEDT)
applications before high-intensity exercise. Photomed Laser Surg
27(4):617623
4. Ihsan FR (2005) Low-level laser therapy accelerates collateral circu-
lation and enhances microcirculation. Photomed Laser Surg 23(3):
289294
5. Passarella S (1989) He-Ne laser irradiation of isolated mitochondria.
J Photochem Photobiol B 3(4):642643
6. Oron U, Ilic S, De Taboada L, Streeter J (2007)Ga-As (808 nm) laser
irradiation enhances ATP production in human neuronal cells in
culture. Photomed Laser Surg 25(3):180182
7. Albuquerque-Pontes GM, Vieira RD, Tomazoni SS, Caires CO,
Nemeth V, Vanin AA, Santos LA, Pinto HD, Marcos RL, Bjordal
JM, de Carvalho PD, Leal-Junior EC. Effect of pre-irradiation with
different doses, wavelengths, and application intervals of low-level
laser therapy on cytochrome c oxidase activity in intact skeletal muscle
of rats. Lasers Med Sci. 2014 Jun 24. doi:10.1007/s10103-014-1616-2
8. Paolillo FR, Corazza AV, Paolillo AR, Borghi-Silva A, Arena R,
Kurachi C, Bagnato VS. Phototherapy during treadmill training
improves quadriceps performance in postmenopausal women.
Climacteric. 2013 Jul 29
9. Chow RT, Heller GZ, Barnsley L (2006) The effect of 300 mW,
830 nm laser on chronic neck pain: a double-blind, randomized,
placebo-controlled study. Pain 124(12):201210
10. Chow RT, Barnsley L (2005) Systematic review of the literature of
low-level laser therapy (LLLT) in the management of neck pain.
Lasers Surg Med 37(1):4652
11. de Almeida P, Tomazoni SS, Frigo L, de Carvalho PT, Vanin AA,
Santos LA, Albuquerque-Pontes GM, De Marchi T, Tairova O,
Marcos RL, Lopes-Martins RÁ, Leal-Junior EC (2014) What is the
Lasers Med Sci
best treatment to decrease pro-inflammatory cytokine release in acute
skeletal muscle injury induced by trauma in rats: low-level laser
therapy, diclofenac, or cryotherapy? Lasers Med Sci 29(2):653658
12. De Marchi T, Leal Junior EC, Bortoli C, Tomazoni SS, Lopes-
Martins RA, Salvador M (2012) Low-level laser therapy (LLLT) in
human progressive-intensity running: effects on exercise perfor-
mance, skeletal muscle status, and oxidative stress. Lasers Med Sci
27(1):231236
13. Miranda EF, Leal-Junior EC, Marchetti PH, Dal Corso S (2014)
Acute effects of light emitting diodes therapy (LEDT) in muscle
function during isometric exercise in patients with chronic obstruc-
tive pulmonary disease: preliminary results of a randomized con-
trolled trial. Lasers Med Sci 29(1):359365
14. Santos LA, Marcos RL, Tomazoni SS, Vanin AA, Antonialli FC,
Grandinetti VD, Albuquerque-Pontes GM, de Paiva PR, Lopes-
Martins RA, de Carvalho PD, Bjordal JM, Leal-Junior EC (2014)
Effects of pre-irradiation of low-level laser therapy with different
doses and wavelengths in skeletal muscle performance, fatigue, and
skeletal muscle damage induced by tetanic contractions in rats.
Lasers Med Sci 29(5):16171626
15. Antonialli FC, De Marchi T, Tomazoni SS, Vanin AA, Dos Santos
Grandinetti V, de Paiva PR, Pinto HD, Miranda EF, de Tarso Camillo
de Carvalho P, Leal-Junior EC (2014) Phototherapy in skeletal muscle
performance and recovery after exercise: effect of combination of
super-pulsed laser and light-emitting diodes. Lasers Med Sci 29(6):
19671976
16. Global Initiative for Chronic Obstructive Lung Disease (2003)
Global strategy of the diagnosis, management and prevention of
chronic obstructive pulmonary disease updated. National Institutes
of Health and National Heart, Lung and Blood Institute. Eur Respir J
22:195
17. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R,
Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R,
Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D,
Pedersen OF, Wanger J (2005) Interpretative strategies for lung
function tests. Eur Respir J 26(5):948968
18. Pereira CAC, Barreto SP, Simões JG (1992) Valores de referência
para espirometria em uma amostra da populacão brasileira adulta. J
Pneumol 18:1022
19. de Oliveira AR, Vanin AA, De Marchi T, Antonialli FC, Grandinetti
Vdos S, de Paiva PR, Albuquerque Pontes GM, Santos LA, Aleixo
Junior Ide O, de Carvalho PT, Bjordal JM, Leal-Junior EC (2014)
What is the ideal dose and power output of low-level laser therapy
(810 nm) on muscle performance and post-exercise recovery? Study
protocol for a double-blind, randomized, placebo-controlled trial.
Trials 15:69
20. Borg G (1990) Psychophysical scaling with applications in physical
work and the perception of exertion. Scand J Work Environ Health
16(Suppl 1):5558
21. Leal-Junior EC, Johnson DS, Saltmarche A, Demchak T (2014)
Adjunctive use of combination of super-pulsed laser and light-
emitting diodes phototherapy on nonspecific knee pain: double-
blinded randomized placebo-controlled trial. Lasers Med Sci 29(6):
18391847
22. Paolillo FR, Milan JC, Aniceto IV, Barreto SG, Rebelatto JR, Borghi-
Silva A, Parizotto NA, Kurachi C, Bagnato VS (2011) Effects of
infrared-LED illumination applied during high-intensity treadmill
training in postmenopausal women. Photomed Laser Surg 29(9):
639645
23. Kelencz CA, Muñoz IS, Amorim CF, Nicolau RA (2010) Effect of
low-power gallium-aluminum-arsenium noncoherent light (640 nm)
on muscle activity: a clinical study. Photomed Laser Surg 28(5):647
652
24. Gorgey AS, Wadee AN, Sobhi NN (2008) The effect of low-level
laser therapy on electrically induced muscle fatigue: a pilot study.
Photomed Laser Surg 26(5):501506
25. Maegawa Y, Itoh T, Hosokawa T, Yaegashi K, Nishi M (2000)
Effects of near-infrared low-level laser irradiation on microcircula-
tion. Lasers Surg Med 27:427437
26. Moga AM, de Marchie M, Saey D, Spahija J (2012) Mechanisms of
non-pharmacologic adjunct therapies used during exercise in COPD.
Respir Med 106(5):614626
Lasers Med Sci
... Empirical use of PBMT in children, adults, and elderly patients with pneumonia, asthma, chronic bronchitis, or pulmonary fibrosis resulted in reduced chest pain and heaviness, normalization of respiratory function, shortened recovery times, and improved immunological and radiological parameters. In these patients, PBMT used in combination with conventional medical treatment was safe and appeared to produce a synergistic effect in healing [6][7][8][9][10]. Recent publications recommend the use of supportive PBMT in COVID-19 patients [11][12][13]. ...
... Lungs score dependent on extent of involvement based on consolidation or ground-glass opacities for each lung, total score is the sum of the score of the lungs: 0 -no involvement; 1 -<25% of lung involved; 2 -25-50% of lung involved; 3 -50-75% of lung involved; 4 ->75% of lung involved. Human trials have shown local and systemic effects of PBMT when applied to quadriceps muscle in patients with chronic obstructive pulmonary disease [10]. Beneficial effects extended beyond improved muscular performance, to statistically significant reductions in dyspnea and fatigue [10]. ...
... Human trials have shown local and systemic effects of PBMT when applied to quadriceps muscle in patients with chronic obstructive pulmonary disease [10]. Beneficial effects extended beyond improved muscular performance, to statistically significant reductions in dyspnea and fatigue [10]. Our patient also reported subjective feelings of improved respiratory function and strength. ...
Article
Full-text available
Coronavirus disease 2019 (COVID-19) is associated with lung inflammation and cytokine storm. Photobiomodulation therapy (PBMT) is a safe, non-invasive therapy with significant anti-inflammatory effects. Adjunct PBMT has been employed in treating patients with lung conditions. Human studies and experimental models of respiratory disease suggest PBMT reduces inflammation and promotes lung healing. This is the first time supportive PBMT was used in a severe case of COVID-19 pneumonia. A 57-year-old African American man with severe COVID-19 received 4 once-daily PBMT sessions by a laser scanner with pulsed 808 nm and super-pulsed 905 nm modes for 28 min. The patient was evaluated before and after treatment via radiological assessment of lung edema (RALE) by CXR, pulmonary severity indices, blood tests, oxygen requirements, and patient questionnaires. Oxygen saturation (SpO2 ) increased from 93–94% to 97–100%, while the oxygen requirement decreased from 2–4 L/min to 1 L/min. The RALE score improved from 8 to 5. The Pneumonia Severity Index improved from Class V (142) to Class II (67). Additional pulmonary indices (Brescia-COVID and SMART-COP) both decreased from 4 to 0. CRP normalized from 15.1 to 1.23. The patient reported substantial improvement in the Community-Acquired Pneumonia assessment tool. This report has presented supportive PBMT in a patient with severe COVID-19 pneumonia. Respiratory indices, radiological findings, oxygen requirements, and patient outcomes improved over several days and without need for a ventilator. Future controlled clinical trials are required to evaluate the effects of PBMT on clinical outcomes in patients with COVID-19 pneumoni
... Miranda et al. first investigated the effects of PBM on the function of quadriceps muscle in patients with COPD and showed that a single application of PBM could alleviate muscle fatigue and increase isometric endurance time [17]. Subsequently, the same research group also confirmed that the application of PBM alone or in combination with a magnetic field could increase exercise capacity and reduce lower extremity fatigue in patients with COPD [18,19]. Regarding the effects of applying PBM to respiratory muscles in patients with COPD, de Souza et al. were the first group to validate that PBM application to respiratory muscles was effective in increasing functional capacity in patients with COPD [20]. ...
... The results demonstrated that LED therapy could delay the development of peripheral muscle fatigue during exercise. They also found that the combination of super-pulsed lasers and LED significantly increased the peak torque, total work, and the maximum isometric contraction of quadriceps muscle and decreased dyspnea and lower limb fatigue in patients with COPD [18]. Recently, Miranda et al. also published a randomized, triple-blinded clinical trial using PBM combined with a magnetic field to stimulate the peripheral muscles in patients with COPD to determine whether there were changes in exercise capacity [19]. ...
Article
Full-text available
Chronic obstructive pulmonary disease (COPD) is a disease characterized by chronic airway inflammation and remodeling and lung parenchymal inflammation and destruction, which result in many pulmonary and extrapulmonary manifestations. The anti-inflammatory effect of photobiomodulation (PBM) has been reported in previous studies. This review was conducted to evaluate the direct effect of PBM on lung inflammation in COPD. The other effects of PBM on modulation of peripheral and respiratory muscle metabolism and angiogenesis in lung tissues were also discussed. The databases of PubMed, Cochrane Library, and Google Scholar were searched to find the relevant studies. Keywords included PBM and related terms, COPD-related signs, and lung inflammation. A total of 12 articles were selected and reviewed in this study. Based on the present review, PBM is helpful in reducing lung inflammation through decreasing the inflammatory cytokines and chemokines at multiple levels and increasing anti-inflammatory cytokines. In addition, PBM also improves both peripheral and respiratory muscle metabolism and promote angiogenesis. This review demonstrated that PBM is a promising adjunctive treatment modality for COPD management which merits further validation.
... The PBM was applied with a properly calibrated probe cluster, containing five LLL diodes (Thor® Photomedicine, DD2, London/UK). PBM was applied at six points demarcated in the quadriceps (two points in the distal region of the VL muscle, two points in the center of the RF muscle, and two points in the distal region of the VM muscle) and two points in the gastrocnemius muscle, bilaterally [31,32]. The PBM application sites were copied on plastic sheets after the first session in order to ensure that the other applications were performed at same sites. ...
... Although the modified Borg's scale of effort perception is not a direct measure of fatigue, we cannot refute that the findings regarding this outcome may also be related to the parameters adopted. In a later study, Miranda et al. [32] used the same scale to measure fatigue in patients with COPD and obtained significant results for this outcome. However, two light sources (LLL and LEDs) with different wavelengths (LLL: 905 nm, LEDs: 875 and 640 nm) were used simultaneously, which could be a hypothesis for the improvement of fatigue. ...
Article
Full-text available
Photobiomodulation (PBM) has been used in different populations as a strategy to attenuate muscle fatigue and improve exercise performance. Recent findings demonstrated that a single session with specific PBM doses during hemodialysis (HD) increased the upper limb muscle strength of chronic kidney failure (CKF) patients. Now, the primary objective of this study was to evaluate the chronic effect of PBM on the functional capacity of this population. Secondarily, we aimed at investigating the effects of PBM on the patients’ strength, muscle thickness and echogenicity, perception of pain, fatigue, and quality of life. A randomized controlled trial was conducted in which the intervention group (IG, n = 14) received 24 sessions of PBM (810 nm, 5 diodes × 200 mW, 30 J/application site) on lower limb during HD. The control group (CG, n = 14) did not receive any physical therapy intervention, it only underwent HD sessions. As a result, there was an increase in the functional capacity (assessed through the six-minute walk test) for the IG compared with the CG [50.7 m (CI95% 15.63; 85.72), p = 0.01, large effect size, d = 1.12], as well as an improvement on lower limb muscle strength (assessed through the sit-and-stand test) [− 7.4 s (CI95% − 4.54; − 10.37), p = 0.00, large effect size, d = 1.99]. For other outcomes evaluated, no significant difference between-group was observed. Finally, PBM applied as monotherapy for 8 weeks in the lower limb improves functional capacity and muscle strength of CKF patients.
... However, the combination of PBMT and SMF (PBMT-SMF) demonstrated remarkable synergy, leading to enhanced electron transfer and consequent activation of the mitochondrial respiratory chain and ATP production [16]. In addition, studies have shown that PBMT-SMF improves muscle performance in healthy individuals [17,18] and athletes [19,20], decreases pain intensity in people undergoing total hip arthroplasty [21], decreases dyspnea intensity in people with chronic obstructive pulmonary disease [22], and improves functional mobility in post-stroke people [23]. ...
Article
Full-text available
Background: Gait deficit is a major complaint in patients after stroke, restricting certain activities of daily living. Photobiomodulation therapy combined with a static magnetic field (PBMT-SMF) has been studied for several diseases, and the two therapies are beneficia. However, their combination has not yet been evaluated in stroke. Therefore, for PBMT-SMF to be used more often and become an adjunctive tool in the rehabilitation of stroke survivors at physical therapy rehabilitation centers and clinics, some important aspects need to be clarified. Purpose: This study aimed to test different doses of PBMT-SMF, to identify the ideal dose to cause immediate effects on the spatiotemporal and kinematic variables of gait in post-stroke patients. Methods: A randomized, triple-blinded, placebo-controlled crossover pilot study was performed. A total of 10 individuals with hemiparesis within 6 months to 5 years since the occurrence of stroke, aged 45-60 years, were included in the study. Participants were randomly assigned and treated with a single PBMT-SMF dose (sham, 10 J, 30 J, or 50 J) on a single application, with one dose per stage at 7-day intervals between stages. PBMT-SMF was applied with a cluster of 12 diodes (4 of 905 nm laser, 4 of 875 nm LEDs, and 4 of 640 nm LEDs, SMF of 35 mT) at 17 sites on both lower limbs after baseline evaluation: plantar flexors (2), knee extensors (9), and flexors (6). The primary outcome was self-selected walking speed, and the secondary outcomes were kinematic parameters. Gait analysis was performed using SMART-D 140® and SMART-D INTEGRATED WORKSTATION®. The outcomes were measured at the end of each stage after the single application of each PBMT-SMF dose tested. Results: No significant differences (p > 0.05) in spatiotemporal variables were observed between the different doses, compared with the baseline evaluation. However, differences (p < 0.05) were observed in the kinematic variable of the hip in the paretic and non-paretic limbs, specifically in the minimum flexion/extension angulation during the support phase (HMST-MIN) in doses 10 J, 30 J, and 50 J. Conclusions: A single application of PBMT-SMF at doses of 10 J, 30 J, and 50 J per site of the lower limbs did not demonstrate positive effects on the spatiotemporal variables, but it promoted immediate effects in the kinematic variables of the hip (maximum and minimum flexion/extension angulation during the support phase) in the paretic and non-paretic limbs in post-stroke people.
... Application is continuous with improved breathing, stimulating the diaphragm (on both sides: leftright) and intercostal muscles (lateral and posterior parts; the anterior part can be effectively treated only on the right side of the body). The intensity is adjusted individually with the control of the motor response; it increases gradually ensuring maximum patient comfort throughout the treatment (Miranda et al., 2015). ...
... In clinical scenario, many studies have also shown that PBMT-sMF has positive effects on muscle performance and post-exercise recovery in athletes and non-athletes [30][31][32][33][34][35][36]. Additionally, such intervention is known to improve the fatigue in the lower limbs of patients with chronic obstructive pulmonary disease [37,38] and stroke [39]. Moreover, this therapy used in conjunction with different training programs has shown improved strength [33] and aerobic endurance [34], besides decreased deconditioning [40]. ...
Article
Full-text available
Abstract Background The direct application of photobiomodulation therapy (PBMT) using low-level laser therapy (LLLT) and light emitting diodes (LEDs) combined with a static magnetic field (sMF) (PBMT-sMF) to target tissues is shown to improve muscle performance and recovery. Studies have reported possible PBMT effects when a local distant to the target tissue is irradiated. Notably, the extent of these effects on musculoskeletal performance and the optimal site of irradiation remain unclear, although this information is clinically important since these aspects could directly affect the magnitude of the effect. Therefore, we investigated the effects of local and non-local PBMT-sMF irradiations on musculoskeletal performance and post-exercise recovery before an eccentric exercise protocol. Methods This randomized, triple-blind (participants, therapists and assessors), placebo-controlled trial included 30 healthy male volunteers randomly assigned to the placebo, local, and non-local groups. Active or placebo PBMT-sMF was applied to 6 sites of the quadriceps muscle of both legs. An eccentric exercise protocol was used to induce fatigue. The primary outcome was peak torque assessed by maximal voluntary contraction (MVC). The secondary outcomes were delayed onset muscle soreness (DOMS) measured by visual analogue scale (VAS), muscle injury assessed by serum creatine kinase activity (CK), and blood lactate levels. Evaluations were performed before the eccentric exercise protocol (baseline), as well as immediately after and 1, 24, 48, and 72 h upon protocol completion. Results Ten volunteers were randomized per group and analysed for all outcomes. Compared to the placebo and non-local groups, irradiation with PBMT-SMF led to statistically significant improvement (p
... Most studies have applied a single PBMT session immediately before exercise. 11,17,20,[32][33][34][35][36] However, evidences from cell culture 37 and animal model 38 studies support that increased ATP content is maximized at 3-6 h after PBMT application. In humans, a recent study from our research group found better results with a combination of two preexercise applications performed at 6 h before and immediately before exercise than with single applications at those time points. ...
Article
Objective: The aim of this study was identifying the best energy dose of photobiomodulation therapy (PBMT) able to improve muscle performance and reduce fatigue during a multiple-set knee extension exercise. Methods: Eighteen physically active men participate in this study. Each participant performed an isokinetic exercise protocol (5 sets of 10 knee extension maximum contractions at 60°·s-1) in six sessions, one week apart. Control condition (no PBMT/placebo treatments) was applied at the first and sixth sessions. Placebo or PBMT with 135, 270, or 540 J/quadriceps were randomly applied at second to fifth sessions. Placebo/PBMT treatments were always applied in two moments: 6h before and immediately before exercise. The isometric and isokinetic concentric peak torques were assessed before and after the exercise protocol. Results: The knee extension exercise performance (total work performed during exercise) was not affected by PBMT (135, 270, and 540 J) compared to placebo treatment. However, all PBMT treatments (135, 270, and 540 J) led to lower percentage drop compared to placebo and control conditions on isometric peak torque (IPT), concentric peak torque (CPT), and concentric work (W). All PBMT doses led to “possibly positive” or “likely positive” effects on IPT, CPT, and W compared to placebo. Conclusion: Our findings demonstrate that PBMT with 135, 270, and 540 J applied in two moments (6 hours before and immediately before exercise) was able to produce the same total work with lower fatigue, in which may to facilitate the performance of additional sets (i.e. higher training volume).
... PBMT-sMF has shown positive effects on muscle performance and post-exercise recovery in athletes and non-athletes. Additionally, such intervention is known to reduce dyspnea and fatigue in the lower limbs of patients with chronic obstructive pulmonary disease [13,23,27,28,29,30,31]. Moreover, this therapy used in conjunction with different exercise programs has shown improved strength and aerobic fitness [18,19]. ...
Preprint
Full-text available
Background The direct application of photobiomodulation therapy (PBMT) combined with a static magnetic field (sMF) (PBMT-sMF) to target tissues is shown to improve muscle performance and recovery. Studies have reported possible PBMT induced systemic effects. Notably, the extent of these effects on musculoskeletal performance and the optimal site of application remain unclear, although this information is clinically important because these factors directly affect the magnitude of the effect. We investigated the effects of PBMT-sMF on musculoskeletal performance and post-exercise recovery of muscles in exercised and non-exercised legs before the implementation of an exercise protocol. Methods This randomized, triple-blind placebo-controlled study included 30 healthy men randomly assigned to the placebo, exercised-leg, and non-exercised leg groups. Active or placebo PBMT-sMF was applied to 6 sites of the quadriceps muscle of both legs. An eccentric exercise protocol was used to induce fatigue. The following parameters were analyzed to evaluate exercise performance: peak torque assessed by maximal voluntary contraction (MVC), delayed muscle pain assessed by the visual analogue scale (VAS), muscle injury assessed by serum creatine kinase (CK), and fatigue assessed by serum lactate levels. Evaluations were performed before implementation of the eccentric (baseline) exercise protocol, as well as immediately after and 1, 24, 48, and 72 hours upon protocol completion. The Bonferroni post-hoc ANOVA test was used considering the level of statistical significance p <0.05. Results Compared to the placebo and systemic groups, irradiation with PBMT-SMF led to statistically significant improvement (p <0.05) with regard to all variables in the exercised-leg group. Results of irradiation in the non-exercised leg group were similar to those in the placebo group with regard to all variables. Conclusion Our results support the current evidence that irradiation of all exercised muscles produces ergogenic effects. PBMT-sMF improved performance and reduced muscle fatigue only when applied locally to muscles involved in physical activity.
Article
Background Severe burns lead to decreased pulmonary function and impaired aerobic capacity for long periods post-injury. Low-level laser therapy is a modality utilized to improve aerobic capacity, enhance exercise performance and increase time until fatigue when utilized before aerobic exercises. Purpose This work aims to determine the impacts of pre-exercise low-level laser therapy on aerobic capacity in burn cases. Participants and Methods Sixty adults burned cases of both sexes, aged from 25 to 40 years, with second-degree healed thermal burns, and the total burned body surface area ranged from 20 to 40% participated in this study after complete wound healing. They were randomly categorized into two groups of equal numbers. The study group received low-level laser therapy before aerobic exercises, three sessions/week for 12 weeks, while the control group performed aerobic exercises three times weekly for 12 weeks. All cases received the routine physical treatment program. Aerobic capacity was assessed for both groups by measuring maximum oxygen consumption and time to exhaustion at baseline and twelve weeks following interventions. Findings There was a statistically significant rise in the mean values of maximum oxygen usage and time to fatigue after 12 weeks of treatment in both groups. However, after comparison, the improvements in the study group were statistically significant than those in the control group with (p < 0.01), (p < 0.05) respectively. Conclusion Low-level laser therapy has a beneficial therapeutic impact on promoting aerobic capacity, improving maximum oxygen consumption, and increasing treadmill time in burned cases when preceding aerobic exercises.
Article
Full-text available
Objective To compare the effects of photobiomodulation therapy (PBMT) and pharmacological therapy (glucocorticoids and non-steroidal anti-inflammatory drugs) applied alone and in different combinations in mdx mice. Methods The animals were randomized and divided into seven experimental groups treated with placebo, PBMT, prednisone, non-steroidal anti-inflammatory drug (NSAIDs), PBMT plus prednisone and PBMT plus NSAID. Wild type animals were used as control. All treatments were performed during 14 consecutive weeks. Muscular morphology, protein expression of dystrophin and functional performance were assessed at the end of the last treatment. Results Both treatments with prednisone and PBMT applied alone or combined, were effective in preserving muscular morphology. In addition, the treatments with PBMT (p = 0.0005), PBMT plus prednisone (p = 0.0048) and PBMT plus NSAID (p = 0.0021) increased dystrophin gene expression compared to placebo-control group. However, in the functional performance the PBMT presented better results compared to glucocorticoids (p<0.0001). In contrast, the use of NSAIDs did not appear to add benefits to skeletal muscle tissue in mdx mice. Conclusion We believe that the promising and optimistic results about the PBMT in skeletal muscle of mdx mice may in the future contribute to this therapy to be considered a safe alternative for patients with Duchenne Muscular Dystrophy (DMD) in a washout period (between treatment periods with glucocorticoids), allowing them to remain receiving effective and safe treatment in this period, avoiding at this way periods without administration of any treatment.
Article
Full-text available
Modulation of cytochrome c oxidase activity has been pointed as a possible key mechanism for low-level laser therapy (LLLT) in unhealthy biological tissues. But recent studies by our research group with LLLT in healthy muscles before exercise found delayed skeletal muscle fatigue development and improved biochemical status in muscle tissue. Therefore, the aim of this study was to evaluate effects of different LLLT doses and wavelengths in cytochrome c oxidase activity in intact skeletal muscle. In this animal experiment, we irradiated the tibialis anterior muscle of rats with three different LLLT doses (1, 3, and 10 J) and wavelengths (660, 830, and 905 nm) with 50 mW power output. After irradiation, the analyses of cytochrome c oxidase expression by immunohistochemistry were analyzed at 5, 10, 30 min and at 1, 2, 12, and 24 h. Our results show that LLLT increased (p < 0.05) cytochrome c oxidase expression mainly with the following wavelengths and doses: 660 nm with 1 J, 830 nm with 3 J, and 905 nm with 1 J at all time points. We conclude that LLLT can increase cytochrome c oxidase activity in intact skeletal muscle and that it contributes to our understanding of how LLLT can enhance performance and protect skeletal muscles against fatigue development and tissue damage. Our findings also lead us to think that the combined use of different wavelengths at the same time can enhance LLLT effects in skeletal muscle performance and other conditions, and it can represent a therapeutic advantage in clinical settings.
Article
Full-text available
Recent studies with phototherapy have shown positive results in enhancement of performance and improvement of recovery when applied before exercise. However, several factors still remain unknown such as therapeutic windows, optimal treatment parameters, and effects of combination of different light sources (laser and LEDs). The aim of this study was to evaluate the effects of phototherapy with the combination of different light sources on skeletal muscle performance and post-exercise recovery, and to establish the optimal energy dose. A randomized, double-blinded, placebo-controlled trial with participation of 40 male healthy untrained volunteers was performed. A single phototherapy intervention was performed immediately after pre-exercise (baseline) maximum voluntary contraction (MVC) with a cluster of 12 diodes (4 of 905 nm lasers-0.3125 mW each, 4 of 875 nm LEDs-17.5 mW each, and 4 of 670 nm LEDs-15 mW each- manufactured by Multi Radiance Medical™) and dose of 10, 30, and 50 J or placebo in six sites of quadriceps. MVC, delayed onset muscle soreness (DOMS), and creatine kinase (CK) activity were analyzed. Assessments were performed before, 1 min, 1, 24, 48, 72, and 96 h after eccentric exercise protocol employed to induce fatigue. Phototherapy increased (p < 0.05) MVC was compared to placebo from immediately after to 96 h after exercise with 10 or 30 J doses (better results with 30 J dose). DOMS was significantly decreased compared to placebo (p < 0.05) with 30 J dose from 24 to 96 h after exercise, and with 50 J dose from immediately after to 96 h after exercise. CK activity was significantly decreased (p < 0.05) compared to placebo with all phototherapy doses from 1 to 96 h after exercise (except for 50 J dose at 96 h). Pre-exercise phototherapy with combination of low-level laser and LEDs, mainly with 30 J dose, significantly increases performance, decreases DOMS, and improves biochemical marker related to skeletal muscle damage.
Article
Full-text available
This study aimed to evaluate the effects of low-level laser therapy (LLLT) immediately before tetanic contractions in skeletal muscle fatigue development and possible tissue damage. Male Wistar rats were divided into two control groups and nine active LLLT groups receiving one of three different laser doses (1, 3, and 10 J) with three different wavelengths (660, 830, and 905 nm) before six tetanic contractions induced by electrical stimulation. Skeletal muscle fatigue development was defined by the percentage (%) of the initial force of each contraction and time until 50 % decay of initial force, while total work was calculated for all six contractions combined. Blood and muscle samples were taken immediately after the sixth contraction. Several LLLT doses showed some positive effects on peak force and time to decay for one or more contractions, but in terms of total work, only 3 J/660 nm and 1 J/905 nm wavelengths prevented significantly (p < 0.05) the development of skeletal muscle fatigue. All doses with wavelengths of 905 nm but only the dose of 1 J with 660 nm wavelength decreased creatine kinase (CK) activity (p < 0.05). Qualitative assessment of morphology revealed lesser tissue damage in most LLLT-treated groups, with doses of 1-3 J/660 nm and 1, 3, and 10 J/905 nm providing the best results. Optimal doses of LLLT significantly delayed the development skeletal muscle performance and protected skeletal muscle tissue against damage. Our findings also demonstrate that optimal doses are partly wavelength specific and, consequently, must be differentiated to obtain optimal effects on development of skeletal muscle fatigue and tissue preservation. Our findings also lead us to think that the combined use of wavelengths at the same time can represent a therapeutic advantage in clinical settings.
Article
Full-text available
Background: Recent studies involving phototherapy applied prior to exercise have demonstrated positive results regarding the attenuation of muscle fatigue and the expression of biochemical markers associated with recovery. However, a number of factors remain unknown, such as the ideal dose and application parameters, mechanisms of action and long-term effects on muscle recovery. The aims of the proposed project are to evaluate the long-term effects of low-level laser therapy on post-exercise musculoskeletal recovery and identify the best dose andapplication power/irradiation time. Design and methods: A double-blind, randomized, placebo-controlled clinical trial with be conducted. After fulfilling the eligibility criteria, 28 high-performance athletes will be allocated to four groups of seven volunteers each. In phase 1, the laser power will be 200 mW and different doses will be tested: Group A (2 J), Group B (6 J), Group C (10 J) and Group D (0 J). In phase 2, the best dose obtained in phase 1 will be used with the same distribution of the volunteers, but with different powers: Group A (100 mW), Group B (200 mW), Group C (400 mW) and Group D (0 mW). The isokinetic test will be performed based on maximum voluntary contraction prior to the application of the laser and after the eccentric contraction protocol, which will also be performed using the isokinetic dynamometer. The following variables related to physical performance will be analyzed: peak torque/maximum voluntary contraction, delayed onset muscle soreness (algometer), biochemical markers of muscle damage, inflammation and oxidative stress. Discussion: Our intention, is to determine optimal laser therapy application parameters capable of slowing down the physiological muscle fatigue process, reducing injuries or micro-injuries in skeletal muscle stemming from physical exertion and accelerating post-exercise muscle recovery. We believe that, unlike drug therapy, LLLT has a biphasic dose-response pattern. Trial registration: The protocol for this study is registered with the Protocol Registry System, ClinicalTrials.gov identifier NCT01844271.
Article
Full-text available
Currently, treatment of muscle injuries represents a challenge in clinical practice. In acute phase, the most employed therapies are cryotherapy and nonsteroidal anti-inflammatory drugs. In the last years, low-level laser therapy (LLLT) has becoming a promising therapeutic agent; however, its effects are not fully known. The aim of this study was to analyze the effects of sodium diclofenac (topical application), cryotherapy, and LLLT on pro-inflammatory cytokine levels after a controlled model of muscle injury. For such, we performed a single trauma in tibialis anterior muscle of rats. After 1 h, animals were treated with sodium diclofenac (11.6 mg/g of solution), cryotherapy (20 min), or LLLT (904 nm; superpulsed; 700 Hz; 60 mW mean output power; 1.67 W/cm(2); 1, 3, 6 or 9 J; 17, 50, 100 or 150 s). Assessment of interleukin-1β and interleukin-6 (IL-1β and IL-6) and tumor necrosis factor-alpha (TNF-α) levels was performed at 6 h after trauma employing enzyme-linked immunosorbent assay method. LLLT with 1 J dose significantly decreased (p < 0.05) IL-1β, IL-6, and TNF-α levels compared to non-treated injured group as well as diclofenac and cryotherapy groups. On the other hand, treatment with diclofenac and cryotherapy does not decrease pro-inflammatory cytokine levels compared to the non-treated injured group. Therefore, we can conclude that 904 nm LLLT with 1 J dose has better effects than topical application of diclofenac or cryotherapy in acute inflammatory phase after muscle trauma.
Article
Full-text available
Patients with chronic obstructive pulmonary disease (COPD) are susceptible to early muscle fatigue. Light-emitting diodes therapy (LEDT) has been used to minimize muscle fatigue in athletes and healthy subjects. The aim of this study is to investigate the acute effects of LEDT on muscle fatigue and perception of effort in patients with COPD during isometric endurance test of the quadriceps femoris (QF). Ten patients (VEF1 50 ± 13 % of predicted) underwent a single LEDT and sham application, 48 h apart, in a randomized crossover design. The LEDT and sham were applied in three localized areas of the QF (rectus femoris, vastus lateralis, and vastus medialis). Before and after exposure to LEDT and sham, the patients performed an isometric endurance test (60 % of the maximum voluntary isometric contraction), until the limit of tolerance concomitant to surface electromyography recording (median frequency as mean outcome). The slope obtained from linear regression analysis of the median frequency (MF) over endurance time was also used as an endurance index. Endurance time increased significantly after exposure to LEDT (from 26 ± 2 to 53 ± 5 s) as compared to sham (from 23 ± 3 to 30 ± 4 s) (F = 64, P = 0.0001). A greater decline in MF was observed during isometric endurance test after sham, compared to LEDT (F = 14.6, P = 0.004). The slope of the MF over time was lower post-LEDT compared to post-sham (-0.7 ± 0.3 vs. -1.5 ± 0.8; P = 0.004). The dyspnea score corrected for endurance time was lower post-LEDT (P = 0.008) but similar for fatigue both post-LEDT and post-sham. A single application of LEDT minimizes muscle fatigue and increases isometric endurance time.
Article
Phototherapy with low-level laser therapy (LLLT) and light-emitting diode therapy (LEDT) has arisen as an interesting alternative to drugs in treatments of musculoskeletal disorders. However, there is a lack of studies investigating the effects of combined use of different wavelengths from different light sources like lasers and light-emitting diodes (LEDs) in skeletal muscle disorders. With this perspective in mind, this study aimed to investigate the effects of phototherapy with combination of different light sources on nonspecific knee pain. It was performed a randomized, placebo-controlled, double-blinded clinical trial. Eighty-six patients rated 30 or greater on the pain visual analogue scale (VAS) were recruited and included in study. Patients of LLLT group received 12 treatments with active phototherapy (with 905 nm super-pulsed laser and 875 and 640 nm LEDs, Manufactured by Multi Radiance Medical, Solon, OH, USA) and conventional treatment (physical therapy or chiropractic care), and patients of placebo group were treated at same way but with placebo phototherapy device. Pain assessments (VAS) were performed at baseline, 4th, 7th, and 10th treatments, after the completion of treatments and at 1-month follow-up visit. Quality of life assessments (SF-36®) were performed at baseline, after the completion of treatments and at 1-month follow-up visit. Our results demonstrate that phototherapy significantly decreased pain (p < 0.05) from 10th treatment to follow-up assessments and significantly improved (p < 0.05) SF-36® physical component summary at posttreatments and follow-up assessments compared to placebo. We conclude that combination of super-pulsed laser, red and infrared LEDs is effective to decrease pain and improve quality of life in patients with knee pain.
Article
Objective: To evaluate the effects of infrared-light-emitting diode (LED) during treadmill training on functional performance. Methods: Thirty postmenopausal women aged 50-60 years were randomly assigned to one of three groups and successfully completed the full study. The three groups were: (1) the LED group, which performed treadmill training associated with phototherapy (n = 10); (2) the exercise group, which carried out treadmill training only (n = 10); and (3) the sedentary group, which neither performed physical training nor underwent phototherapy (n = 10). Training was performed over a period of 6 months, twice a week for 45 min per session at 85-90% of maximal heart rate, which was obtained during progressive exercise testing. The irradiation parameters were 100 mW, 39 mW/cm(2) and 108 J/cm(2) for 45 min. Quadriceps performance was measured during isokinetic exercise testing at 60°/s and 300°/s. Results: Peak torque did not differ amongst the groups. However, the results showed significantly higher values of power and total work for the LED group (∆ = 21 ± 6 W and ∆ = 634 ± 156 J, p < 0.05) when compared to both the exercise group (∆ = 13 ± 10 W and = 410 ± 270 J) and the sedentary group (∆ = 10 ± 9 W and ∆ = 357 ± 327 J). Fatigue was also significantly lower in the LED group (∆ = -7 ± 4%, p < 0.05) compared to both the exercise group (∆ = 3 ± 8%) and the sedentary group (∆ = -2 ± 6%). Conclusions: Infrared-LED during treadmill training may improve quadriceps power and reduce peripheral fatigue in postmenopausal women.